Although there have been a multitude of potential biomarkers that in preliminary studies were proven to be better than PSA, there are few studies of diagnostic accuracy for csPCa detection that evaluated men with persistently elevated PSA and several prostate biopsies negative for PCa. This evidence concerns the gene KLK3 and posterior cortical atrophy.